# Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN)

> **NCT00337051** · PHASE3 · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 120 (actual)

## Conditions studied

- End-stage Chronic Renal Disease
- Severe Acute Kidney Failure
- Renal Transplantation

## Interventions

- **DRUG:** Sevoflurane
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT00337051
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2010-02
- **Final completion:** 2010-06
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2026-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00337051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00337051, "Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN)". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT00337051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*